ARTICLE | Company News
CGI, Genentech deal
October 9, 2006 7:00 AM UTC
CGI granted DNA exclusive worldwide rights to discover, develop and commercialize small molecule therapeutics against an undisclosed CGI target for cancer and autoimmune indications. CGI will retain r...